Open-label Extension Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Neovascular ("Wet") Age-related Macular Degeneration (AMD)
Clinical trial NCT00964795 · COMPLETED
Trial details
- NCT number
- NCT00964795
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2013-08-01
- Enrollment
- 323
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.